Loading institutional data...
Loading institutional data...
Strong institutional accumulation: ownership increased +6.84% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company has neither positive free cash flow nor a collected share count, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
4/7 of the 9 checks — 2 couldn't be scored (see above), so the score is out of the 7 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 5 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 99%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 5 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $64000 is below the $31M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2025-09-30 (10-Q).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest.
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Top 21 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-07-30 · 50d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $31.5M 100.0% | $29.1M 100.0% | $30.0M 100.0% | — | — |
| Cost of Revenue | $26.6M 84.4% | $25.5M 87.6% | $31.3M 104.3% | — | — |
| Gross Profit | $3.5M 11.2% | $2.2M 7.5% | -$1.3M -4.3% | $175.9M | $172.5M |
| Research & Development | $202K 0.6% | $197K 0.7% | $460K 1.5% | — | — |
| Selling, General & Admin | $14.5M 46.2% | $22.6M 77.6% | $18.6M 62.2% | — | — |
| Operating Income | -$11.0M -35.1% | -$20.4M -70.1% | -$19.9M -66.5% | -$2.9M | -$428K |
| Interest Expense | $6.0M 19.0% | $5.1M 17.4% | $7.3M 24.3% | — | — |
| Interest & Investment Income | — | — | $5K 0.0% | $4K | — |
| Other Income (Expense), net | -$8.0M -25.4% | -$5.1M -17.4% | -$7.9M -26.2% | — | — |
| Pretax Income | -$19.0M -60.5% | -$25.5M -87.5% | — | — | — |
| Income Tax Expense | -$67K -0.2% | -$135K -0.5% | -$336K -1.1% | — | — |
| Net Income | -$19.0M -60.3% | -$25.3M -87.0% | -$27.5M -91.6% | -$303K | -$408K |
| Per Share | |||||
| EPS (Basic) | $-0.89 | $-1.25 | $-2.56 | — | — |
| EPS (Diluted) | $-0.89 | $-1.25 | $-2.56 | — | — |
| Weighted Avg Shares (Basic) | 21.4M | 20.3M | 10.8M | — | — |
| Weighted Avg Shares (Diluted) | 21.4M | 20.3M | 10.8M | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-07-30
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cost of Revenue | — | — | 104.3 | 87.6 | 84.4 |
| Gross Profit | — | — | -4.3 | 7.5 | 11.2 |
| R&D | — | — | 1.5 | 0.7 | 0.6 |
| SG&A | — | — | 62.2 | 77.6 | 46.2 |
| Operating Income | — | — | -66.5 | -70.1 | -35.1 |
| Income Tax | — | — | -1.1 | -0.5 | -0.2 |
| Net Income | — | — | -91.6 | -87.0 | -60.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on BRLSW: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.